Overview
Description
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Healthcare Healthcare Equipment General Medical Devices Denmark
Financials
Key metrics
Market capitalisation, EUR | 3,761.82 m |
EPS, EUR | 0.19 |
P/B ratio | 4.69 |
P/E ratio | 75.02 |
Dividend yield | 0.36% |
Income statement (2024)
Revenue, EUR | 722.95 m |
Net income, EUR | 31.51 m |
Profit margin | 4.36% |
What ETF is Ambu A/S in?
There are 35 ETFs which contain Ambu A/S. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ambu A/S is the Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.